GGrantIndex
← Search

ALENDRONATE, MIACALCIN IN POSTMENOPAUSAL OSTEOPOROSIS

$0M01FY2000RRNIH

Medical University Of South Carolina, Charleston SC

Investigators

Linked publications & trials

Abstract

This study is designed to compare the effectiveness of two medications. Fosamax (alendronate sodium tablets) and Miacalcin (calcitonin-salmon) Nasal Spray. Currently prescribed in the United States for treatment of postmenopausal osteoporosis, and to assess safety and tolerability of their treatments. All patients will also receive Vitamin D and calcium supplements, if needed. Calcium is an essential nutrient for healthy bones; many clinical studies have shown that increasing calcium intake may protect the skeleton from further bone loss. Approximately 320 postmenopausal women will be entered into this study.

View original record on NIH RePORTER →